Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure

JACC: Cardiovascular Imaging

Volumn 5, Issue 11, 2012, Pages 1139-1146

  Shah, Amil M ^a   Bourgoun, Mikhail ^a   Narula, Jagat ^b   Jacobson, Arnold F ^c   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c GE HEALTHCARE   (United States)

Author keywords

ejection fraction; heart failure; meta iodobenzylguanidine; prognosis; sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEATH; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TO MEDIASTINUM RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; OUTCOME OF EDUCATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SYMPATHETIC INNERVATION; SYSTOLIC HEART FAILURE;

3-IODOBENZYLGUANIDINE; AGED; ARRHYTHMIAS, CARDIAC; DISEASE PROGRESSION; FEMALE; HEART; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 84869127326     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2012.02.019     Document Type: Article

References (25)

1. S.D. Solomon, D. Wang, P. Finn Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program Circulation 110 2005 2180 2183
2. M.R. Zile, W.H. Gaasch, I.S. Anand Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial Circulation 121 2010 1393 1405
3. S.D. Solomon, N. Anavekar, H. Skali Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients Circulation 112 2005 3738 3744
4. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J Am Coll Cardiol 51 2008 e1 e62
5. R.B. Himelman, M.M. Cassidy, J.S. Landzberg, N.B. Schiller Reproducibility of quantitative two-dimensional echocardiography Am Heart J 115 1988 425 431
6. P.S. Douglas, J.M. DeCara, R.B. Devereux Echocardiographic imaging in clinical trials: American Society of Echocardiography standards for echocardiography core laboratories: endorsed by the American College of Cardiology Foundation J Am Soc Echocardiogr 22 2009 755 765
7. E.S. Chung, R.P. Katra, S. Ghio Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction >35%: a PROSPECT trial substudy Eur J Heart Fail 12 2010 581 587
8. I. Carrio, M.R. Cowie, J. Yamazaki, J. Udelson, P.G. Camici Cardiac sympathetic imaging with mIBG in heart failure J Am Coll Cardiol Img 3 2010 92 100
9. M.I. Travin Cardiac neuronal imaging at the edge of clinical application Cardiol Clin 27 2009 311 327
10. 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systemic review Eur Heart J 29 2008 1147 1159
11. T. Wakabayashi, T. Nakata, A. Hashimoto Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death J Nucl Med 42 2001 1757 1767
12. A.F. Jacobson, R. Senior, M.D. Cerqueira Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study J Am Coll Cardiol 55 2010 2212 2221
13. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials J Nucl Cardiol 16 2009 113 121
14. R.M. Lang, M. Bierig, R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
15. H. Uno, T. Cai, L. Tian, L.J. Wei Graphical procedures for evaluating overall and subject-specific incremental values for new predictors with censored event time data Biometrics 67 2011 1389 1396
16. E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
17. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
18. D. Agostini, H.J. Verberne, W. Burchert 123I-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multi-center study Eur J Nucl Med Mol Imaging 35 2008 535 546
19. S. Fujimoto, H. Amano, A. Inoue Usefulness of 123I- metaiodobenzylguanidine myocardial scintigraphy in the prediction of cardiac events in patients with cardiomyopathy showing stabilization of symptoms or preserved cardiac function Ann Nucl Med 18 2004 591 598
20. M. Kyuma, T. Nakata, A. Hashimoto Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure J Nucl Med 45 2004 155 163
21. S. Tamaki, T. Yamada, Y. Okuyama Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction J Am Coll Cardiol 53 2009 426 435
22. L.S. Chen, S. Zhou, M.C. Fishbein, P.S. Chen New perspectives on the role of autonomic nervous system in the genesis of arrhythmias J Cardiovasc Electrophysiol 18 2007 123 127
23. D. Nagahara, T. Nakata, A. Hashimoto Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function J Nucl Med 49 2008 225 233
24. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study Circ Cardiovasc Imaging 1 2008 131 140
25. E.P. Gordon, I. Schnittger, P.J. Fitzgerald, P. Williams, R.L. Popp Reproducibility of left ventricular volumes by two-dimensional echocardiography J Am Coll Cardiol 2 1983 506 513